Send the following on WhatsApp
Continue to Chat協和麒麟株式會社(Kyowa Kirin)腫瘤性軟骨症罕藥 CRYSVITA 獲得歐盟 EC 核准 https://geneonline.news/kyowa-kirin-pmt-crysvita-ec-approval/
協和麒麟株式會社(Kyowa Kirin)腫瘤性軟骨症罕藥 CRYSVITA 獲得歐盟 EC 核准 https://geneonline.news/kyowa-kirin-pmt-crysvita-ec-approval/